Laurent Meijer
Laboratory of Molecular and Cellular Neuroscience
The Rockefeller University
1230 York Avenue
New York
USA
Name/email consistency: high
- Pharmacological inhibitors of glycogen synthase kinase 3. Meijer, L., Flajolet, M., Greengard, P. Trends Pharmacol. Sci. (2004)
- GSK-3-selective inhibitors derived from Tyrian purple indirubins. Meijer, L., Skaltsounis, A.L., Magiatis, P., Polychronopoulos, P., Knockaert, M., Leost, M., Ryan, X.P., Vonica, C.A., Brivanlou, A., Dajani, R., Crovace, C., Tarricone, C., Musacchio, A., Roe, S.M., Pearl, L., Greengard, P. Chem. Biol. (2003)
- Inhibition of cyclin-dependent kinases, GSK-3beta and CK1 by hymenialdisine, a marine sponge constituent. Meijer, L., Thunnissen, A.M., White, A.W., Garnier, M., Nikolic, M., Tsai, L.H., Walter, J., Cleverley, K.E., Salinas, P.C., Wu, Y.Z., Biernat, J., Mandelkow, E.M., Kim, S.H., Pettit, G.R. Chem. Biol. (2000)
- Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Meijer, L., Borgne, A., Mulner, O., Chong, J.P., Blow, J.J., Inagaki, N., Inagaki, M., Delcros, J.G., Moulinoux, J.P. Eur. J. Biochem. (1997)
- Chemical inhibitors of cyclin-dependent kinases. Meijer, L. Trends Cell Biol. (1996)